HC Wainwright Reaffirms Buy Rating for Alpha Tau Medical (NASDAQ:DRTS)
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $9.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 243.51% from the company’s previous close. […]
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $9.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 243.51% from the company’s previous close. […]
